003042.SZ
Shandong Sino-Agri United Biotechnology Co., Ltd.
SZSE · Basic Materials · C 制造业 · CN
CNY 13.78
−2.75%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.0B | 1.9B | 2.0B | 1.7B | 1.9B |
| Cost of Revenue | 1.8B | 1.7B | 1.8B | 1.5B | 1.5B |
| Gross Profit | 212.4M | 194.7M | 231.6M | 151.3M | 408.0M |
| Operating Expenses | |||||
| R&D Expense | 78.6M | 78.8M | 85.7M | 98.5M | 103.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 158.0M | 159.1M | 172.1M | 178.0M | 152.0M |
| Selling & Marketing Expense | 63.0M | 61.6M | 58.8M | 61.1M | 45.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 359.2M | 350.4M | 355.9M | 370.5M | 328.3M |
| Cost and Expenses | 2.1B | 2.0B | 2.1B | 1.9B | 1.9B |
| Operating Income (EBIT) | (163.2M) | (161.0M) | (135.6M) | (237.2M) | 71.7M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (163.9M) | (161.6M) | (136.2M) | (236.6M) | 71.0M |
| Income Tax Expense | (25.2M) | (25.0M) | (13.8M) | (44.1M) | (2.1M) |
| Bottom Line | |||||
| Net Income | (138.7M) | (136.6M) | (122.5M) | (192.5M) | 73.1M |
| Earnings from Cont. Ops | (138.7M) | (136.6M) | (122.5M) | (192.5M) | 73.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (138.7M) | (136.6M) | (122.5M) | (192.5M) | 73.1M |
| Per Share | |||||
| Basic EPS | (CN¥0.97) | (CN¥0.96) | (CN¥0.86) | (CN¥1.35) | CN¥0.51 |
| Diluted EPS | (CN¥0.97) | (CN¥0.96) | (CN¥0.86) | (CN¥1.35) | CN¥0.51 |
| Revenue Per Share | CN¥9.93 | CN¥13.08 | CN¥14.14 | CN¥11.79 | CN¥13.48 |
| Shares | |||||
| Basic Shares Outstanding | 199.8M | 142.3M | 142.4M | 142.6M | 143.4M |
| Diluted Shares Outstanding | 199.8M | 142.3M | 142.4M | 142.6M | 143.4M |
| Profitability Metrics | |||||
| EBITDA | — | 59.3M | 42.0M | (71.4M) | 224.1M |
| D&A | — | 220.2M | 177.6M | 165.8M | 152.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026